Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA6 | P23280 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | HNF4A | P41235 | 1/20 | 0.54 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.51 |
| ▸ | G6PD | P11413 | 1/20 | 0.48 |
| ▸ | CASP7 | P55210 | 1/20 | 0.48 |
| ▸ | CASP6 | P55212 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9717027 | 0.98 | ALDH1A1 (0.53) | ALDH1A1KDM4ESMN1; SMN2CA12CA1 | |
| SCHEMBL10824560 | 0.94 | ALDH1A1 (0.52) | ALDH1A1KDM4ESMN1; SMN2CA12CA1 | |
| (Chloromethyl)Benzene SCHEMBL7196363 | 0.92 | HNF4A (0.47) | ALDH1A1KDM4ESMN1; SMN2CA12CA1 | |
| SCHEMBL29383769 | 0.89 | TSHR (0.46) | ALDH1A1KDM4ESMN1; SMN2CA12CA1 | |
| SCHEMBL11044630 | 0.88 | ALDH1A1 (0.58) | ALDH1A1KDM4ESMN1; SMN2CA12CA1 | |
| SCHEMBL27488099 | 0.88 | ALDH1A1 (0.54) | ALDH1A1KDM4ESMN1; SMN2CA12CA1 | |
| SCHEMBL27543078 | 0.86 | LIG1 (0.49) | ALDH1A1HNF4ATSHRTDP1KMT2A | |
| SCHEMBL9244765 | 0.85 | HNF4A (0.59) | ALDH1A1KDM4ESMN1; SMN2CA12CA1 | |
| SCHEMBL11213066 | 0.84 | ALDH1A1 (0.52) | ALDH1A1KDM4ESMN1; SMN2CA12CA1 | |
| SCHEMBL9076064 | 0.84 | LTB4R (0.52) | ALDH1A1KDM4ESMN1; SMN2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120154564-A | Preparation method of stable veterinary oral paste composition | 北京欧博方医药科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-114989501-A | Non-toxic environment-friendly foamed natural rubber and preparation method thereof | 唐雪金 | 2022-09-02 | — | — | CN | claimed |
| EP-0329460-B1 | STABILISED MACROLIDE COMPOSITIONS | AMERICAN CYANAMID COMPANY (US) | 1992-05-20 | — | — | EP | claimed |
| JP-5078610-A | — | — | None | — | — | JP | disclosed |
| CN-118632933-A | Screening method for substance inhibiting odor of 4-methylacetophenone and method for inhibiting odor of 4-methylacetophenone | 味之素株式会社 | 2024-09-10 | — | — | CN | disclosed |
| CN-118591301-A | Method for inhibiting odor of p-cresol | 味之素株式会社 | 2024-09-03 | — | — | CN | disclosed |
| CN-117396490-A | Bicyclic heterocyclic compounds for the prevention and treatment of viral infections | BM医药咨询有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-113820920-B | Photosensitive resin composition, method for producing cured relief pattern, and semiconductor device | 旭化成株式会社 | 2023-07-04 | — | — | CN | disclosed |
| CN-116332809-A | Process for producing alkylamine derivative and intermediate for production thereof | 味之素株式会社 | 2023-06-27 | — | — | CN | disclosed |
| CN-115536556-A | Process for producing alkylamine derivative and intermediate for producing the same | 味之素株式会社 | 2022-12-30 | — | — | CN | disclosed |
| CN-108699580-B | Heparan sulphate with a high 3-O-sulphation ratio in the glucosamine residue | 味之素株式会社 | 2022-09-23 | — | — | CN | disclosed |
| EP-1869269-A1 | ANTI-CASTER SURFACE LAMINATE | LG Chemical Co. Ltd (KR) | 2007-12-26 | — | — | EP | disclosed |
| WO-2006109914-A1 | ANTI-CASTER SURFACE LAMINATE | LG CHEM, LTD. (KR) | 2006-10-19 | — | — | WO | disclosed |
| US-6927290-B2 | Production of mixed acid anhydride and amide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-08-09 | — | — | US | disclosed |
| EP-1160236-B1 | Production of mixed acid anhydride and amine compound | SUMITOMO CHEMICAL CO (JP) | 2005-05-25 | — | — | EP | disclosed |
| US-20040210059-A1 | Production of mixed acid anhydride and amide compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-10-21 | — | — | US | disclosed |
| US-6753431-B2 | REACTING A CARBAMATE DERIVATIVE WITH CARBOXYLIC AND HALOFORMIC ACID DERIVATIVES | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2004-06-22 | — | — | US | disclosed |
| US-20020032346-A1 | Production of mixed acid anhydride and amide compound | SUMITOMO CHEMICAL CO., LTD. | 2002-03-14 | — | — | US | disclosed |
| EP-1160236-A2 | Production of mixed acid anhydride and amine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-12-05 | — | — | EP | disclosed |
| JP-H0578610-A | INK COMPOSITION FOR INK JET RECORDING | RICOH CO LTD | 1993-03-30 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040210059-A1 | Production of mixed acid anhydride and amide compound | CA2, CA1, CA3 | ALDH1A1 543/4885KDM4E 3359/4885SMN1; SMN2 2886/4885 |
| US-20020032346-A1 | Production of mixed acid anhydride and amide compound | CA2, CA1, CA3 | ALDH1A1 543/4885KDM4E 3359/4885SMN1; SMN2 2886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.